Michelle Lord Wernle, PA-C

Michelle Wernle practices at Dent Neurologic Institute in Amherst, New York.

Michelle Wernle's NPI, 1265160998, was assigned on August 10, 2022. Michelle Wernle holds New York license 031634.

Michelle Wernle's primary practice is Dent Neurologic Institute, at 3980 Sheridan Dr, Amherst, NY 14226-1727. The practice phone is (716) 250-2000.

Michelle Wernle's primary practice is Dent Neurologic Institute in Amherst, New York. The medical group on file is DENT Neurologic Institute. Dmand AI also links Michelle Wernle to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Wernle practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Michelle Wernle's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Michelle Wernle's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists fibromyalgia and chronic pain among the conditions Michelle Wernle treats.

CMS data shows 1,407 Medicare services from Michelle Wernle across 7 procedure codes in 2024, for 182 Medicare patients. Medicare paid $25,283 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Michelle Wernle in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michelle Wernle's median patient age at 63, with 65% women.

In 2024, Michelle Wernle wrote 1,686 Medicare Part D claims for 544 patients. 95% of them were for generic drugs. CMS names the drug for 1,456 of them, across 34 drugs with 11 or more claims each, at $44,321 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 44 out of 100 for Michelle Wernle for performance year 2024, reported as part of a group. Michelle Wernle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michelle Wernle as offering telehealth.

CMS Open Payments shows 139 general payments to Michelle Wernle from 35 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. TG Therapeutics, Inc. paid the most, $945.